CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: In a more recent study, all four T cell clones isolated from CML patients after BMT, which had exhibited cytotoxicity for autologous tumor cells, were immunophenotyped as CD4+CD8− cells [25].